{"component": "clause", "props": {"groups": [{"samples": [{"hash": "84KgHjqRqR6", "uri": "/contracts/84KgHjqRqR6#genentech", "label": "Research Collaboration and License Agreement (AC Immune SA)", "score": 27.6995208761, "published": true}, {"hash": "jP428uhHxV5", "uri": "/contracts/jP428uhHxV5#genentech", "label": "Research Collaboration and License Agreement (AC Immune SA)", "score": 27.4120465435, "published": true}, {"hash": "btHBgzctqz2", "uri": "/contracts/btHBgzctqz2#genentech", "label": "Research Collaboration and License Agreement (AC Immune SA)", "score": 26.8945927447, "published": true}], "snippet_links": [{"key": "products-liability-and-completed-operations", "type": "clause", "offset": [58, 101]}, {"key": "clinical-trials", "type": "definition", "offset": [125, 140]}, {"key": "minimum-amount", "type": "definition", "offset": [149, 163]}, {"key": "per-occurrence", "type": "clause", "offset": [175, 189]}, {"key": "combined-single-limit", "type": "clause", "offset": [191, 212]}, {"key": "bodily-injury-and-property-damage-liability", "type": "clause", "offset": [217, 260]}], "size": 6, "snippet": "Genentech shall maintain on an ongoing basis coverage for Products Liability and Completed Operations including coverage for Clinical Trials, in the minimum amount of [*****] per occurrence, combined single limit for bodily injury and property damage liability.", "hash": "6c1c5f83ca344e73f9a56cbe9ba74050", "id": 1}, {"samples": [{"hash": "84KgHjqRqR6", "uri": "/contracts/84KgHjqRqR6#genentech", "label": "Research Collaboration and License Agreement (AC Immune SA)", "score": 27.6995208761, "published": true}, {"hash": "jP428uhHxV5", "uri": "/contracts/jP428uhHxV5#genentech", "label": "Research Collaboration and License Agreement (AC Immune SA)", "score": 27.4120465435, "published": true}, {"hash": "btHBgzctqz2", "uri": "/contracts/btHBgzctqz2#genentech", "label": "Research Collaboration and License Agreement (AC Immune SA)", "score": 26.8945927447, "published": true}], "snippet_links": [{"key": "contractors-and-agents", "type": "clause", "offset": [46, 68]}, {"key": "affiliates-and-third-parties", "type": "clause", "offset": [78, 106]}, {"key": "this-agreement", "type": "clause", "offset": [135, 149]}, {"key": "program-ip-rights", "type": "definition", "offset": [235, 252]}, {"key": "genentech-ip-rights", "type": "definition", "offset": [257, 276]}, {"key": "to-practice", "type": "clause", "offset": [320, 331]}], "size": 6, "snippet": "Genentech shall require all of its employees, contractors and agents, and any Affiliates and Third Parties working on its behalf under this Agreement (and their respective employees, contractors and agents), to assign to Genentech any Program IP Rights and Genentech IP Rights, created, discovered, conceived or reduced to practice by such employees, contractors or agents or Affiliates or Third Parties.", "hash": "a10cc2a0bb8eb7102414e61b66b1e3fa", "id": 2}, {"samples": [{"hash": "gKH6Rukubqs", "uri": "/contracts/gKH6Rukubqs#genentech", "label": "Option, License, and Collaboration Agreement", "score": 31.340862423, "published": true}, {"hash": "eAharHezhsr", "uri": "/contracts/eAharHezhsr#genentech", "label": "Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC)", "score": 29.7008898015, "published": true}, {"hash": "q4N0M9Xkus", "uri": "/contracts/q4N0M9Xkus#genentech", "label": "Option, License, and Collaboration Agreement (Arvinas Holding Company, LLC)", "score": 29.6598220397, "published": true}], "snippet_links": [{"key": "research-program", "type": "clause", "offset": [51, 67]}, {"key": "number-of", "type": "clause", "offset": [79, 88]}], "size": 4, "snippet": "Genentech shall perform its obligations under each Research Program using such number of Genentech FTEs as it deems appropriate to conduct activities delegated to it under such Research Program.", "hash": "cf6037741005e8cddfe6ae5335d8458c", "id": 3}, {"samples": [{"hash": "l4XpingNeaf", "uri": "/contracts/l4XpingNeaf#genentech", "label": "Collaboration and License Agreement (Xencor Inc)", "score": 30.3497604381, "published": true}], "snippet_links": [{"key": "between-the-parties", "type": "clause", "offset": [3, 22]}, {"key": "genentech-ip", "type": "definition", "offset": [59, 71]}, {"key": "program-ip", "type": "definition", "offset": [84, 94]}], "size": 2, "snippet": "As between the Parties, Genentech shall solely own (a) the Genentech IP (other than Program IP) and (b) Genentech Core Inventions; and", "hash": "52afc1ea4ba9e44f45feb50637e2f2a9", "id": 4}, {"samples": [{"hash": "jbeLhycVUBy", "uri": "/contracts/jbeLhycVUBy#genentech", "label": "Phase Ib/Ii Combination Study Agreement (Corvus Pharmaceuticals, Inc.)", "score": 28.5865845311, "published": true}], "snippet_links": [{"key": "the-sponsor", "type": "clause", "offset": [19, 30]}, {"key": "use-commercially-reasonable-efforts", "type": "clause", "offset": [74, 109]}, {"key": "project-participants", "type": "definition", "offset": [123, 143]}, {"key": "in-accordance-with", "type": "definition", "offset": [179, 197]}, {"key": "this-agreement", "type": "clause", "offset": [198, 212]}, {"key": "applicable-law", "type": "clause", "offset": [241, 255]}, {"key": "responsible-for", "type": "clause", "offset": [276, 291]}, {"key": "all-approvals", "type": "clause", "offset": [302, 315]}, {"key": "regulatory-authorities", "type": "definition", "offset": [388, 410]}, {"key": "conduct-of-the-project", "type": "clause", "offset": [500, 522]}, {"key": "conduct-of-the-study", "type": "clause", "offset": [562, 582]}, {"key": "participating-sites", "type": "definition", "offset": [590, 609]}, {"key": "in-no-event-shall", "type": "clause", "offset": [611, 628]}], "size": 1, "snippet": "Genentech shall be the Sponsor of the Study. Genentech shall conduct, and use commercially reasonable efforts to cause all Project Participants to conduct and complete, the Study in accordance with this Agreement, the Genentech Protocol and Applicable Law. Genentech shall be responsible for obtaining all approvals and clearances necessary to conduct the Study, including approvals from Regulatory Authorities and IRBs and customs clearances. Genentech is solely responsible for the performance and conduct of the Project Participants, including monitoring the conduct of the Study at the Participating Sites. In no event shall Corvus or any of its Affiliates be deemed a Sponsor of the Study.", "hash": "0b0dee1c7fecdf4054394f84a8071255", "id": 5}, {"samples": [{"hash": "9adGLziOusM", "uri": "/contracts/9adGLziOusM#genentech", "label": "Overview of Major Events and Policy Issues in Eu Competition Law", "score": 24.6878850103, "published": true}], "snippet_links": [{"key": "july-2016", "type": "clause", "offset": [3, 12]}, {"key": "court-of-appeal", "type": "clause", "offset": [65, 80]}, {"key": "competition-law", "type": "definition", "offset": [92, 107]}, {"key": "the-case", "type": "definition", "offset": [132, 140]}, {"key": "entered-into", "type": "clause", "offset": [227, 239]}, {"key": "licensing-agreement", "type": "clause", "offset": [249, 268]}, {"key": "by-sanofi", "type": "clause", "offset": [323, 332]}, {"key": "licence-to-use", "type": "clause", "offset": [372, 386]}], "size": 1, "snippet": "In July 2016, the ECJ gave a ruling on a question from the Paris Court of Appeal as regards competition law and patent licences.101 The case arose from an arbitration which had been appealed to the French courts. Genentech had entered into a patent licensing agreement with Behringswerke, a company subsequently taken over by Sanofi-Aventis, for a worldwide non-exclusive licence to use a patented \u201ccytomegalovirus enhancer\u201d to make a product used for 91 Opinion of \u2587.\u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 in VM Remonts EU:C:2015:797. 92 Opinion of \u2587.\u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 in VM Remonts EU:C:2015:797 at [63]. 93 Opinion of \u2587.\u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 in VM Remonts EU:C:2015:797 at [65]. 94 Opinion of \u2587.\u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 in VM Remonts EU:C:2015:797 at [69]. 95 Opinion of \u2587.\u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 in VM Remonts EU:C:2015:797 at [70]. 96 Opinion of \u2587.\u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 in VM Remonts EU:C:2015:797 at [25]. 97 Opinion of \u2587.\u2587. \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 in VM Remonts EU:C:2015:797 at [27].", "hash": "ab3ac5d5deb104f50d49a159743a256f", "id": 6}, {"samples": [{"hash": "lwp6S3ahdcG", "uri": "/contracts/lwp6S3ahdcG#genentech", "label": "Manufacturing and Supply Agreement (Osi Pharmaceuticals Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "authority-and", "type": "clause", "offset": [99, 112]}, {"key": "right-to-enter-into-this-agreement", "type": "clause", "offset": [123, 157]}, {"key": "obligations-under-this-agreement", "type": "clause", "offset": [177, 209]}, {"key": "reasonable-inquiry", "type": "definition", "offset": [257, 275]}, {"key": "employees-with", "type": "clause", "offset": [314, 328]}, {"key": "expertise-and-experience", "type": "clause", "offset": [334, 358]}, {"key": "in-this-agreement", "type": "clause", "offset": [427, 444]}], "size": 1, "snippet": "Genentech hereby represents and warrants to OSI that:\n11.1.1 Genentech has the corporate power and authority and the legal right to enter into this Agreement and to perform its obligations under this Agreement; and\n11.1.2 to the best of its knowledge after reasonable inquiry, Genentech has a sufficient number of employees with such expertise and experience as is necessary or appropriate to fulfill its obligations set forth in this Agreement.", "hash": "e8b391a0c5ea926b93275b6143aedcf1", "id": 7}, {"samples": [{"hash": "ik1iNM4XXsf", "uri": "/contracts/ik1iNM4XXsf#genentech", "label": "Agreement Between Genentech, Inc. And F. Hoffmann La Roche LTD Regarding Commercialization of Genentech's Products Outside the United States (Genentech Inc)", "score": 18.0, "published": true}], "snippet_links": [{"key": "the-chairman", "type": "clause", "offset": [0, 12]}, {"key": "joint-commercialization-committee", "type": "definition", "offset": [49, 82]}, {"key": "mutually-agreed", "type": "clause", "offset": [135, 150]}, {"key": "video-conference", "type": "definition", "offset": [167, 183]}], "size": 1, "snippet": "The chairman will call and chair meetings of the Joint Commercialization Committee which will be held at GENENTECH's facilities unless mutually agreed otherwise or by video conference where feasible.", "hash": "b5c2a7215b0526213c4d5514efb69f3b", "id": 8}, {"samples": [{"hash": "l4XpingNeaf", "uri": "/contracts/l4XpingNeaf#genentech", "label": "Collaboration and License Agreement (Xencor Inc)", "score": 30.3497604381, "published": true}], "snippet_links": [{"key": "contractors-and-agents", "type": "clause", "offset": [46, 68]}, {"key": "affiliates-and-third-parties", "type": "clause", "offset": [78, 106]}, {"key": "this-agreement", "type": "clause", "offset": [135, 149]}, {"key": "patents-and-other-intellectual-property-rights", "type": "clause", "offset": [291, 337]}, {"key": "to-practice", "type": "clause", "offset": [407, 418]}, {"key": "in-the-case", "type": "clause", "offset": [508, 519]}, {"key": "to-the-extent", "type": "clause", "offset": [547, 560]}, {"key": "assignment-of", "type": "definition", "offset": [569, 582]}, {"key": "the-development", "type": "clause", "offset": [665, 680]}, {"key": "commercialization-and-manufacturing", "type": "clause", "offset": [682, 717]}, {"key": "collaboration-products", "type": "definition", "offset": [750, 772]}, {"key": "obligations-of", "type": "clause", "offset": [801, 815]}, {"key": "section-1032", "type": "clause", "offset": [821, 835]}, {"key": "all-rights", "type": "clause", "offset": [880, 890]}], "size": 1, "snippet": "Genentech shall require all of its employees, contractors and agents, and any Affiliates and Third Parties working on its behalf under this Agreement (and their respective employees, contractors and agents), to assign to Genentech Know-How and other intellectual property (together with all Patents and other intellectual property rights CONFIDENTIALEXECUTION COPY therein) developed, conceived, or reduced to practice by such employees, contractors or agents or Affiliates or Third Parties; provided, that, in the case of any such Third Parties, to the extent that an assignment of such intellectual property cannot be obtained, then licenses sufficient to enable the Development, Commercialization and Manufacturing of Collaboration Constructs and Collaboration Products hereunder shall satisfy the obligations of this Section 10.3.2. Genentech hereby assigns to Xencor any and all rights, title, or interest that Genentech may have in any Xencor Core Invention and [***].", "hash": "6e655c3cdaf968452716fd9a1f61a2ac", "id": 9}, {"samples": [{"hash": "9zTAHhBvb1o", "uri": "/contracts/9zTAHhBvb1o#genentech", "label": "Toll Manufacturing Agreement (Genentech Inc)", "score": 21.0, "published": true}], "snippet_links": [{"key": "as-of-the-effective-date", "type": "clause", "offset": [63, 87]}, {"key": "representation-and-warranty", "type": "definition", "offset": [115, 142]}, {"key": "section-161", "type": "clause", "offset": [161, 173]}, {"key": "working-cell-bank", "type": "definition", "offset": [247, 264]}, {"key": "genentech-confidential-information", "type": "definition", "offset": [266, 300]}, {"key": "without-limitation", "type": "clause", "offset": [313, 331]}, {"key": "manufacturing-documentation", "type": "definition", "offset": [337, 364]}, {"key": "information-to-be-supplied", "type": "clause", "offset": [375, 401]}, {"key": "by-genentech", "type": "clause", "offset": [402, 414]}, {"key": "the-transaction-agreements", "type": "clause", "offset": [437, 463]}, {"key": "in-accordance-with", "type": "definition", "offset": [508, 526]}, {"key": "terms-and-conditions-of-the-transaction", "type": "clause", "offset": [531, 570]}, {"key": "members-of-the", "type": "clause", "offset": [695, 709]}, {"key": "legal-department", "type": "definition", "offset": [720, 736]}, {"key": "duty-of-inquiry", "type": "clause", "offset": [773, 788]}, {"key": "with-respect-to", "type": "clause", "offset": [835, 850]}, {"key": "no-lawsuit", "type": "clause", "offset": [876, 886]}, {"key": "in-the-territory", "type": "clause", "offset": [913, 929]}, {"key": "patent-infringement", "type": "clause", "offset": [943, 962]}, {"key": "sale-of-the-product", "type": "definition", "offset": [985, 1004]}, {"key": "manufacturing-process", "type": "clause", "offset": [1021, 1042]}, {"key": "proprietary-materials", "type": "definition", "offset": [1093, 1114]}, {"key": "raw-materials", "type": "definition", "offset": [1118, 1131]}, {"key": "to-the-extent", "type": "clause", "offset": [1133, 1146]}, {"key": "written-notice", "type": "definition", "offset": [1546, 1560]}, {"key": "third-party-patent", "type": "definition", "offset": [1588, 1606]}, {"key": "united-states-patent", "type": "definition", "offset": [2167, 2187]}, {"key": "owned-or-controlled", "type": "definition", "offset": [2188, 2207]}, {"key": "of-claims", "type": "clause", "offset": [2455, 2464]}, {"key": "patent-applications", "type": "definition", "offset": [2485, 2504]}, {"key": "no-third-party", "type": "clause", "offset": [2531, 2545]}, {"key": "license-agreements", "type": "definition", "offset": [2908, 2926]}, {"key": "those-terms", "type": "clause", "offset": [2950, 2961]}, {"key": "exhibit-a", "type": "clause", "offset": [2977, 2986]}, {"key": "the-right", "type": "clause", "offset": [3011, 3020]}, {"key": "to-manufacture", "type": "definition", "offset": [3037, 3051]}, {"key": "manufacture-of-the-product", "type": "clause", "offset": [3107, 3133]}, {"key": "terms-and-conditions-of-this-agreement", "type": "clause", "offset": [3171, 3209]}, {"key": "infringement-of-the", "type": "clause", "offset": [3245, 3264]}, {"key": "authority-and", "type": "clause", "offset": [3319, 3332]}, {"key": "right-to-enter-into-this-agreement", "type": "clause", "offset": [3343, 3377]}, {"key": "obligations-under-this-agreement", "type": "clause", "offset": [3397, 3429]}], "size": 1, "snippet": "Genentech hereby represents and warrants to Wyeth that:\n16.1.1 As of the Effective Date, and without expanding any representation and warranty set forth in this Section 16.1, Genentech owns or has sufficient right, title or interest in and to the Working Cell Bank, Genentech Confidential Information (including, without limitation, the Manufacturing Documentation), and all information to be supplied by Genentech to Wyeth under any of the Transaction Agreements to supply the same to Wyeth for Wyeth's use in accordance with the terms and conditions of the Transaction Agreements;\n16.1.2 Except as otherwise disclosed to Wyeth by Genentech as of the Effective Date, to the actual knowledge of members of the Genentech legal department as of the Effective Date, without a duty of inquiry and without conducting any additional inquiry with respect to this Agreement, there is no lawsuit pending against Genentech in the Territory that alleges patent infringement by the manufacture or sale of the Product, the use of the Manufacturing Process or the use or propagation of any of the Genentech Proprietary Materials or Raw Materials (to the extent such use or propagation is undertaken as part of performing the Manufacturing Process);\n16.1.3 Except as otherwise disclosed to Wyeth by Genentech as of the Effective Date, to the actual knowledge of members of the Genentech legal department as of the Effective Date, without a duty of inquiry and without conducting any additional inquiry with respect to this Agreement, Genentech has not received written notice alleging infringement of a Third Party patent by the manufacture or sale of the Product;\n16.1.4 To the actual knowledge of members of the Genentech legal department as of the Effective Date, without a duty of inquiry and without conducting any additional inquiry with respect to this Agreement, the manufacture, use or sale of the Product, the use of the Manufacturing Process (including the use or propagation of any of the Genentech Proprietary Materials or the Raw Materials to the extent such use or propagation is undertaken as part of performing the Manufacturing Process) do not infringe any issued United States patent owned or controlled by any Third Party;\n16.1.5 To the actual knowledge of members of the Genentech legal department as of the Effective Date, without a duty of inquiry and without conducting any additional inquiry with respect to this Agreement, based upon the scope of claims and content of such patent applications as of the Effective Date, no Third Party has any United States patent application pending which, if issued, would be infringed by the manufacture, use or sale of the Product, the use of the Manufacturing Process, including the use of any of the Genentech Proprietary Materials or the Raw Materials to the extent such use is undertaken as part of performing the Manufacturing Process;\n16.1.6 Genentech's license agreements to the [*] and [*] (as those terms are defined in Exhibit A hereto) grant Genentech the right to retain Wyeth to manufacture Product as provided hereunder and as a result, Wyeth's manufacture of the Product hereunder and in accordance with the terms and conditions of this Agreement would not constitute an unlicensed infringement of the [*]; and\n16.1.7 Genentech has the corporate power and authority and the legal right to enter into this Agreement and to perform its obligations under this Agreement.", "hash": "59272b93d286427ea772444a24881305", "id": 10}], "next_curs": "ClISTGoVc35sYXdpbnNpZGVyY29udHJhY3Rzci4LEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhJnZW5lbnRlY2gjMDAwMDAwMGEMogECZW4YACAA", "clause": {"children": [], "title": "Genentech", "parents": [["assignments", "Assignments"], ["insurance", "Insurance"], ["intellectual-property-patent-prosecution-and-maintenance", "Intellectual Property Patent Prosecution and Maintenance"], ["research-program", "Research Program"], ["conduct-costs", "Conduct Costs"]], "size": 22, "id": "genentech", "related": [["licensee", "Licensee", "Licensee"], ["licensor", "Licensor", "Licensor"], ["manufacturing-technology-transfer", "Manufacturing Technology Transfer", "Manufacturing Technology Transfer"], ["licensed-technology", "Licensed Technology", "Licensed Technology"], ["sublicensees", "Sublicensees", "Sublicensees"]], "related_snippets": [], "updated": "2025-07-07T12:37:53+00:00"}, "json": true, "cursor": ""}}